Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
1hck | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
1hck | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 1.000 | |
1b38 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.582 | |
1b39 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.530 | |
2c5y | MTW | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.515 | |
2a4l | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
2b52 | D42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.491 | |
3lfn | A27 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.491 | |
2xmy | CDK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.490 | |
1y91 | CT9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.487 | |
3r83 | Z14 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
2vtp | LZ9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
3rpo | 24Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
2c6o | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
3r7y | Z04 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
4fl2 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.469 | |
2r64 | 740 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
3s1h | 56Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
2r3j | SCJ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
3r8l | Z30 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
4fkv | 61K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
3nie | ANP | Mitogen-activated protein kinase | / | 0.466 | |
3pls | ANP | Macrophage-stimulating protein receptor | 2.7.10.1 | 0.466 | |
1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
1w8c | N69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.462 | |
1pxl | CK4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
2exm | ZIP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
5cno | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
1oit | HDT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3qtx | X43 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
4oh4 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.453 | |
1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
5cnn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
4lyn | 1YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
1pxo | CK7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
3r8v | Z62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
4h3q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.450 | |
2a0c | CK9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2duv | 371 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3qx2 | X63 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
2vtq | LZA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
2y9q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.444 | |
1h0w | 207 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
2ds1 | 1CD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1daw | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
1e1x | NW1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
2vth | LZ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3qtu | X44 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3rk7 | 08Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
4eon | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 |